[Insulin secretion after oral and intravenous administration of various 1st and 2d generation sulfonylurea derivatives in equipotential dosage].
D000284:Administration, Oral; D005905:Glyburide / Q000494:pharmacology; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D007328:Insulin; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005905:Glyburide
Zur Frage der Insulinsekretion nach oraler und i.v. Applikation verschiedener Sulfonylharnstoffderivate der 1. und 2. Generation in äquipotenter Dosierung.